Capsaicin: Clinical Trials

20 trials of Capsaicin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 3 recruiting, 3 terminated, 1 unknown. 20 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 320Completed 13, Recruiting 3, Terminated 3, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Capsaicin: new trials by email Literature Review of Capsaicin trials Research Report on Capsaicin

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
Capsaicin 8% patch, Hydrocolloid dressing - Neuropathic Pain, Chronic Pain
Phase 3RecruitingUniversity Hospital, Brest462024-03-052026-06-15
Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
Capsaicin 179 Mg Cutaneous Patch, Capsaicin low concentration patch (capsaicin 0,04%, 3,2 mg/cm2) - Coccyx Disorder, Neuropathic Pain
Phase 3RecruitingNantes University Hospital1882023-11-082026-10-09
Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy
Capsaicin, Duloxetine - Chemotherapy-induced Peripheral Neuropathy
Phase 3RecruitingInstitut Cancerologie de l'Ouest2742023-10-202026-03-31
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
Qutenza (capsaicin) 8% topical system, capsaicin 0.04% topical system - Post Surgical Neuropathic Pain
Phase 3CompletedAveritas Pharma, Inc.4122021-07-132026-09-21
Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery
Capsaicin, Pregabalin - Breast Cancer Patient
Phase 3CompletedInstitut Cancerologie de l'Ouest1402019-03-192026-05-05
An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA
CNTX-4975-05, Lidocaine without epinephrine, ElastoGel - Knee Osteoarthritis
Phase 3CompletedCentrexion Therapeutics8542018-09-182022-03-09
Capsaicin Effect on Cytokines Profile in Dyslipidemia
Capsaicin, Magnesia calcinada - Dyslipidemia, Overweight or Obesity
Phase 2 / Phase 3UnknownUniversity of Guadalajara172016-10-012016-07-19
Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch
QUTENZA®, hypnotic message, music therapy - Pain
Phase 3CompletedInstitut de Cancérologie de Lorraine692016-08-302022-04-07
Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain
Diclofenac, Capsaicin, Placebo - Acute Pain
Phase 3CompletedBoehringer Ingelheim7462016-05-092019-05-06
Capsaicin Patches In Knee Osteoarthritis In Obese Patients
capsaicin 8% patches (Qutenza), Placebo patches - Pain
Phase 3TerminatedNadine ATTAL222015-07-012019-04-17
Capsaicin Patch 8 % for the Treatment of Persistent Pain After Inguinal Herniotomy
capsaicin patch (qutenza), Placebo - Persistent Pain After Inguinal Herniotomy
Phase 3TerminatedCopenhagen University Hospital, Rigshospitalet502012-08-012014-02-26
A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)
Capsaicin 8%, Placebo - Diabetic Peripheral Neuropathy, Pain
Phase 3CompletedAstellas Pharma Inc3692012-02-012015-11-04
A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients
QUTENZA - Painful Diabetic Peripheral Neuropathy (PDPN)
Phase 3CompletedAstellas Pharma Inc4682011-11-012015-10-14
Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.
Capsaicin - Diabetic Neuropathy, Painful
Phase 3CompletedArafarma Group, S.A.1612010-11-042021-09-14
Efficacy of Topical Capsaicin Cream for Stable Angina
Capsaicin, Placebo cream - Stable Angina
Phase 3TerminatedNeal Weintraub72010-10-012015-06-25
Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy
Capsaicin, placebo - Diabetic Polyneuropathy
Phase 2 / Phase 3CompletedThammasat University332009-10-012012-05-09
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
NGX-4010, 8% capsaicin patch, 0.04% capsaicin patch - Pain, HIV Infections
Phase 3CompletedNeurogesX4942006-06-012011-06-14
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NGX-4010 - Peripheral Nervous System Diseases, Pain
Phase 3CompletedNeurogesX4002006-03-012008-03-06
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NGX-4010 - Peripheral Nervous System Diseases, Pain
Phase 3CompletedNeurogesX4002005-06-012008-03-06
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
capsaicin, placebo, radiation therapy - Head and Neck Cancer, Radiation Toxicity
Phase 3CompletedAlliance for Clinical Trials in Oncology181998-10-012016-07-13

Conditions studied

Pain (7)  ·  Neuralgia (6)  ·  Peripheral Nervous System Diseases (3)  ·  Diabetic Neuropathies (2)  ·  Herpes Zoster (2)  ·  Neuralgia, Postherpetic (2)  ·  Obesity (2)  ·  Osteoarthritis, Knee (2)  ·  Acute Pain (1)  ·  Angina, Stable (1)  ·  Chronic Pain (1)  ·  Dyslipidemias (1)  ·  HIV Infections (1)  ·  Head and Neck Neoplasms (1)  ·  Neuritis (1)

Sponsors

NeurogesX (3)  ·  Astellas Pharma Inc (2)  ·  Institut Cancerologie de l'Ouest (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Arafarma Group, S.A. (1)  ·  Averitas Pharma, Inc. (1)  ·  Boehringer Ingelheim (1)  ·  Centrexion Therapeutics (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Institut de Cancérologie de Lorraine (1)  ·  Nadine ATTAL (1)  ·  Nantes University Hospital (1)  ·  Neal Weintraub (1)  ·  Thammasat University (1)  ·  University Hospital, Brest (1)

Countries

France (8)  ·  United States (5)  ·  Germany (2)  ·  Netherlands (2)  ·  Poland (2)  ·  Russia (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Italy (1)  ·  Thailand (1)  ·  Ukraine (1)

Top investigators

Jeffrey Tobias, MD (2)  ·  Claire Carette (1)  ·  Dr. Raffaelle Carraro (1)  ·  Ernesto J Ramirez Lizardo, PhD (1)  ·  Faisal M Khan, MD (1)  ·  Kongkiat Kulkantrakorn, MD (1)  ·  Randall M. Stevens, MD (1)  ·  Scott Okuno, MD (1)

Results publications

PMID 18977178, PMID 21087403, PMID 22067661, PMID 23351618, PMID 25290151, PMID 27746370, PMID 27919222, PMID 32221866, PMID 34044838

NIH funding

2009 (1), 2015 (1)